Episode 72: Updates in Epilepsy Treatment
Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Christopher Elder, MD. [LISTEN TIME: 32 minutes]
Episode 72 of the NeurologyLive®
The Mind Moments® podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.
Episode 72, "Updates in Epilepsy Treatment," features an exclusive interview with Christopher Elder, MD, clinical assistant professor of neurology, Comprehensive Epilepsy Center, NYU Langone Health. He joined the show to talk about the latest updates in the care of patients with epilepsy, the clinical therapeutic pipeline developments on the horizon, and the need to continue stressing conversations around sudden unexpected death in epilepsy (SUDEP).
This episode is brought to you by Medical World News. Check out new episodes of a variety of shows, airing every single day, only on
The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:
FDA Approves Midazolam Autoinjector for Status Epilepticus Sirolimus Topical Gel Available for Facial Angiofibroma Associated With Tuberous Sclerosis Complex FDA Lifts Hold on Phase 2 Trial of SRP-5051 in DMD Amenable to Exon 51 Skipping Philips Respironics Recalls Masks for BPAP and CPAP Machines After Safety Concerns FDA Advisory Committee Votes to Recommend AMX0035 for Treatment of ALS
EPISODE BREAKDOWN
1:15 – The rise of neurostimulation in epilepsy care
4:00 – Increasing implantation of minimally invasive options
5:15 – Patient reception to nontherapeutic approaches
7:45 – The impact of cenobamate (Xcopri; SK Life Science) on the paradigm
10:35 – Managing refractory epilepsy
12:00 – Upcoming options for those with generalized epilepsy
13:50 – Neurology News Minute
18:30 – Path forward for gene and cell therapies in epilepsy
21:00 – The need to improve early recognition of epilepsy
25:20 – Standardizing questionnaires and information for epilepsy
27:00 – The need to continue discussing SUDEP
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
Pathophysiology of Myasthenia GravisSeptember 18th 2025
